Edwards Lifesciences Treats 1st Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease
Edwards Lifesciences notes the HARPOON system uses a less-invasive technique than open-heart surgery in order to treat a type of heart disease called severe degenerative mitral valve regurgitation, which occurs when there is damage to the mitral valve that prevents proper functioning of the valve.